Tianzhi Zhao

Development of [177Lu]Lu-LNC1003 for radioligand therapy of prostate cancer with a moderate level of PSMA expression

Zijian Zhou, Zhide Guo, Xianzhong Zhang, 2023, European Journal of Nuclear Medicine and Molecular Imaging.